BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35014484)

  • 1. Design of a Targeting and Oxygen-Independent Platform to Improve Photodynamic Therapy: A Proof of Concept.
    Larue L; Moussounda Moussounda Koumba T; Le Breton N; Vileno B; Arnoux P; Jouan-Hureaux V; Boura C; Audran G; Bikanga R; Marque SRA; Acherar S; Frochot C
    ACS Appl Bio Mater; 2021 Feb; 4(2):1330-1339. PubMed ID: 35014484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Peptide-Conjugated Chlorin-Type Photosensitizer Targeting Neuropilin-1 for Anti-Vascular Targeted Photodynamic Therapy.
    Kamarulzaman EE; Gazzali AM; Acherar S; Frochot C; Barberi-Heyob M; Boura C; Chaimbault P; Sibille E; Wahab HA; Vanderesse R
    Int J Mol Sci; 2015 Oct; 16(10):24059-80. PubMed ID: 26473840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional nanoparticles as photosensitizer delivery carriers for enhanced photodynamic cancer therapy.
    Zhang Y; Wang B; Zhao R; Zhang Q; Kong X
    Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111099. PubMed ID: 32600703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular and cellular targeting for photodynamic therapy.
    Chen B; Pogue BW; Hoopes PJ; Hasan T
    Crit Rev Eukaryot Gene Expr; 2006; 16(4):279-305. PubMed ID: 17206921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma.
    Thomas E; Colombeau L; Gries M; Peterlini T; Mathieu C; Thomas N; Boura C; Frochot C; Vanderesse R; Lux F; Barberi-Heyob M; Tillement O
    Int J Nanomedicine; 2017; 12():7075-7088. PubMed ID: 29026302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug targeting strategies for photodynamic therapy.
    Schmitt F; Juillerat-Jeanneret L
    Anticancer Agents Med Chem; 2012 Jun; 12(5):500-25. PubMed ID: 22292760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-Based Cancer Therapeutics for Targeted Photodynamic Therapy.
    Cao B; Xu H; Yang M; Mao C
    Methods Mol Biol; 2018; 1776():643-652. PubMed ID: 29869271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanophotosensitizers toward advanced photodynamic therapy of Cancer.
    Lim CK; Heo J; Shin S; Jeong K; Seo YH; Jang WD; Park CR; Park SY; Kim S; Kwon IC
    Cancer Lett; 2013 Jul; 334(2):176-87. PubMed ID: 23017942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inorganic nanoparticles for enhanced photodynamic cancer therapy.
    Cheng SH; Lo LW
    Curr Drug Discov Technol; 2011 Sep; 8(3):250-68. PubMed ID: 21644924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted photodynamic therapy.
    Solban N; Rizvi I; Hasan T
    Lasers Surg Med; 2006 Jun; 38(5):522-31. PubMed ID: 16671102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced Photosensitizer Activation Strategies for Smarter Photodynamic Therapy Beacons.
    Luby BM; Walsh CD; Zheng G
    Angew Chem Int Ed Engl; 2019 Feb; 58(9):2558-2569. PubMed ID: 29890024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Delivery Systems for Phthalocyanines for Photodynamic Therapy.
    Rak J; Pouckova P; Benes J; Vetvicka D
    Anticancer Res; 2019 Jul; 39(7):3323-3339. PubMed ID: 31262853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activatable Photosensitizer for Smart Photodynamic Therapy Triggered by Reactive Oxygen Species in Tumor Cells.
    Yuan B; Wang H; Xu JF; Zhang X
    ACS Appl Mater Interfaces; 2020 Jun; 12(24):26982-26990. PubMed ID: 32432853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted photodynamic-induced singlet oxygen production by peptide-conjugated biodegradable nanoparticles for treatment of skin melanoma.
    Sebak AA; Gomaa IEO; ElMeshad AN; AbdelKader MH
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():181-189. PubMed ID: 29885810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiscale Selectivity and in vivo Biodistribution of NRP-1
    Gries M; Thomas N; Daouk J; Rocchi P; Choulier L; Jubréaux J; Pierson J; Reinhard A; Jouan-Hureaux V; Chateau A; Acherar S; Frochot C; Lux F; Tillement O; Barberi-Heyob M
    Int J Nanomedicine; 2020; 15():8739-8758. PubMed ID: 33223826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid Liquid Crystal Nanocarriers for Enhanced Zinc Phthalocyanine-Mediated Photodynamic Therapy.
    Nag OK; Naciri J; Erickson JS; Oh E; Delehanty JB
    Bioconjug Chem; 2018 Aug; 29(8):2701-2714. PubMed ID: 29990422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bifunctional Photosensitizer for Enhanced Fractional Photodynamic Therapy: Singlet Oxygen Generation in the Presence and Absence of Light.
    Turan IS; Yildiz D; Turksoy A; Gunaydin G; Akkaya EU
    Angew Chem Int Ed Engl; 2016 Feb; 55(8):2875-8. PubMed ID: 26799149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smart Nanoreactors for pH-Responsive Tumor Homing, Mitochondria-Targeting, and Enhanced Photodynamic-Immunotherapy of Cancer.
    Yang G; Xu L; Xu J; Zhang R; Song G; Chao Y; Feng L; Han F; Dong Z; Li B; Liu Z
    Nano Lett; 2018 Apr; 18(4):2475-2484. PubMed ID: 29565139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of photosensitization processes for an improved targeted photodynamic therapy.
    Verhille M; Couleaud P; Vanderesse R; Brault D; Barberi-Heyob M; Frochot C
    Curr Med Chem; 2010; 17(32):3925-43. PubMed ID: 20858211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy: current status and future directions.
    Benov L
    Med Princ Pract; 2015; 24 Suppl 1(Suppl 1):14-28. PubMed ID: 24820409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.